Fresenius Medical Care Stock Total Debt
| FME Stock | EUR 41.35 0.01 0.02% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
Fresenius |
Fresenius Medical Care Company Total Debt Analysis
Fresenius Medical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Fresenius Medical Total Debt | 7.17 B |
Most of Fresenius Medical's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Fresenius Medical Care has a Total Debt of 7.17 B. This is 160.65% higher than that of the Healthcare sector and 137.85% higher than that of the Medical Care industry. The total debt for all Germany stocks is 34.86% lower than that of the firm.
Fresenius Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in total debt category among its peers.
Fresenius Fundamentals
| Return On Equity | 0.0608 | |||
| Return On Asset | 0.0277 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 21.59 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.61 % | |||
| Price To Earning | 15.86 X | |||
| Price To Book | 0.59 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 19.4 B | |||
| Gross Profit | 5.31 B | |||
| EBITDA | 3.42 B | |||
| Net Income | 673.4 M | |||
| Cash And Equivalents | 922 M | |||
| Cash Per Share | 3.04 X | |||
| Total Debt | 7.17 B | |||
| Debt To Equity | 104.70 % | |||
| Current Ratio | 0.99 X | |||
| Book Value Per Share | 47.68 X | |||
| Cash Flow From Operations | 2.17 B | |||
| Earnings Per Share | 2.22 X | |||
| Price To Earnings To Growth | 1.05 X | |||
| Number Of Employees | 128.04 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 10.47 B | |||
| Total Asset | 35.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.19 % | |||
| Net Asset | 35.75 B | |||
| Last Dividend Paid | 1.12 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Fresenius Stock
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.